Enhancing Diagnosis, Prognosis, and Therapeutic Outcome Prediction of Gliomas Using Genomics
- 1 March 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in OMICS: A Journal of Integrative Biology
- Vol. 16 (3), 113-122
- https://doi.org/10.1089/omi.2011.0031
Abstract
Malignant gliomas are the most frequent type of primary brain tumors. Patients' outcome has not improved despite new therapeutics, thus underscoring the need for a better understanding of their genetics and a fresh approach to treatment. The lack of reproducibility in the classification of many gliomas presents an opportunity where genomics may be paramount for accurate diagnosis and therefore best for therapeutic decisions. The aim of this work is to identify large and focal copy number abnormalities (CNA) and loss of heterozygosity (LOH) events in a malignant glioma population. We hypothesized that these explorations will allow discovery of genetic markers that may improve diagnosis and predict outcome. DNA from glioma specimens were subjected to CNA and LOH analyses. Our studies revealed more than 4000 CNA and several LOH loci. Losses of chromosomes 1p and/or 19q, 10, 13, 14, and 22 and gains of 7, 19, and 20 were found. Several of these alterations correlated significantly with histology and grade. Further, LOH was detected at numerous chromosomes. Interestingly, several of these loci harbor genes with potential or reported tumor suppressor properties. These novel genetic signatures may lead to critical insights into diagnosis, classification, prognosis, and design of individualized therapies.Keywords
This publication has 49 references indexed in Scilit:
- Interpreting aCGH-defined karyotypic changes in gliomas using copy number status, loss of heterozygosity and allelic ratiosExperimental and Molecular Pathology, 2010
- A multigene predictor of outcome in glioblastomaNeuro-Oncology, 2009
- Targeted Therapy for Malignant Glioma Patients: Lessons Learned and the Road AheadNeurotherapeutics, 2009
- A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal CancerScience, 2009
- Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesisProceedings of the National Academy of Sciences, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic β-catenin and affects membrane distribution of β-catenin/E-cadherin complexes in cancer cellsCellular Signalling, 2008
- Gene Expression Signatures, Clinicopathological Features, and Individualized Therapy in Breast CancerJAMA, 2008
- Protein-tyrosine phosphatases and cancerNature Reviews Cancer, 2006
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences of the United States of America, 2004